Skip to main content
Equibles
VRNO logo

VRNO · Verano Holdings Corp. · Metrics

Track VRNO — free

Use VRNO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VRNO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.96 +0.19 (+3.29%) At close · Sep 14
Rebalance outlook locked
Market Cap
$422.47M
Shares
73.22M

VRNO metrics

64 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$5.96
Market cap
$422.47M

Price action

20 metrics
Price change (1W)
-5.9%
Price change (30D)
-1.0%
Price change (3M)
-4.6%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
52.1%
Annualized volatility (3M)
52.1%
Beta
—
RSI (14D)
46.2
Price vs SMA 50
-0.2%
Price vs SMA 200
—
Avg volume (3M)
103,852
Relative volume
0.7
Average dollar volume
$599,932

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
73.22M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.9×
reciprocal yield 114.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 197.8%
P / book
0.6
reciprocal yield 160.1%
FCF yield
10.8%
TTM · current market cap
Buyback yield
—
P / FCF
9.2
reciprocal yield 10.8%
P / operating cash flow
4.7
reciprocal yield 21.2%
Earnings yield
-61.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.4×
reciprocal yield 73.3%
EV / revenue historical average (5Y)
1.4×
reciprocal yield 71.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
98.6×
reciprocal yield 1.0%
EV / EBITDA historical average (5Y)
98.6×
reciprocal yield 1.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
47.8%
Operating margin
-15.8%
Trailing 12 months
Net margin
-30.9%
Gross profit (TTM)
$399.61M
Operating profit (TTM)
−$132.06M
Net income (TTM)
−$258.48M
Trailing 12 months
Diluted EPS (TTM)
$-3.56
FCF margin
5.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$48.46

Growth

11 metrics
Revenue growth YoY
+7.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$835.52M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.3%
Year over year · more shares
Revenue CAGR (3Y)
-2.2%
Revenue CAGR (5Y)
+29.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+0.3%

Quality

14 metrics
Return on equity
-38.2%
Return on assets
-15.2%
Debt / equity
0.6
Current ratio
3.7
EBITDA (TTM)
−$12.57M
Free cash flow (TTM)
$45.68M
Quick ratio
1.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$307.42M
Latest balance sheet
Cash & equivalents
$85.19M
Total assets
$1.70B
Total debt
$392.61M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$89.38M
Capital expenditures (TTM)
$43.70M
R&D (TTM)
—
SG&A (TTM)
$344.77M
Stock compensation (TTM)
$12.77M
R&D / revenue
—
Stock compensation / revenue
1.5%

Ownership (13F)

3 metrics
13F filers
2
13F filer change QoQ
0
Institutional ownership
0.2%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
30 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1848416 CUSIP 92339H200 Visit website Investor relations